
Overview
Vantage Trading (Sp. z o.o.) is a Polish limited liability company operating in the pharmaceutical products sector. The company offers a range of pharmaceutical products and lists procurement among its activities.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $11,909 |
Filing timeliness
Financial statements were filed on time, on average 27 days early.
- 202515/07/2026
- 202422/05/2025
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
Websites
- vantages.plVANTAGE TRADINGNginx
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Nataliia Kumar age 55 | 30 | $405.19 | 30% |
Ashok Kumar Brak Dannych age 58 | 70 | $945.43 | 70% |
The articles of association require board approval for share transfers.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-10-01.
52 1090 1870 0000 0001 5515 1939
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Novo Nordisk Pharma sp. z o.o. | $126,524,177.00 | novonordisk.pl | ||
| Magnapharm Poland sp. z o.o. | $90,512,785.67 | magnapharm.pl | ||
| Ceva Animal Health Polska sp. z o.o. | $41,565,571.90 | ceva.pl | ||
| Swiss House sp. z o.o. + limited partnership | $35,355,240.15 | shpharma.pl | ||
| New Approach sp. z o.o. | $22,884,976.86 | newapproach.pl | ||
| Midas Pharma Polska sp. z o.o. | $20,847,894.51 | midas-pharma.com | ||
| Medyk-Lek Panek sp. z o.o. sp. k. | $20,167,374.20 | medyklek.pl | ||
| Woerwag Pharma Polska sp. z o.o. | $16,858,061.27 | woerwagpharma.pl | ||
| Qpharma sp. z o.o. | $16,010,159.04 | qpharma.pl | ||
| Ibsa Poland sp. z o.o. | $8,664,746.04 | ibsapoland.pl |
FAQ
Last updated: 2026-08-24